alendronate has been researched along with cyclin d1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franke, HR; Verdijk, R; Vermes, I; Wolbers, F | 1 |
| Rogers, HL; Rogers, MJ; Sutherland, KA; Tosh, D | 1 |
2 other study(ies) available for alendronate and cyclin d1
| Article | Year |
|---|---|
Differential effects of bisphosphonates on breast cancer cell lines.
Topics: Alendronate; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Clodronic Acid; Cyclin D1; Diphosphonates; DNA Fragmentation; Etidronic Acid; Female; Flow Cytometry; Humans; Ibandronic Acid; Imidazoles; Pamidronate; Risedronic Acid; RNA, Messenger; Zoledronic Acid | 2007 |
RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro.
Topics: Alendronate; Animals; Apoptosis; bcl-X Protein; Blotting, Western; Clodronic Acid; Cyclin D1; Diphosphonates; In Vitro Techniques; Mice; Microscopy, Electron, Scanning; Myeloid Cell Leukemia Sequence 1 Protein; Osteoclasts; Proto-Oncogene Proteins c-bcl-2; Rabbits; RANK Ligand | 2009 |